These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8732374)

  • 41. Audit of prehospital thrombolysis by general practitioners in peripheral practices in Grampian.
    Rawles J; Sinclair C; Jennings K; Ritchie L; Waugh N
    Heart; 1998 Sep; 80(3):231-4. PubMed ID: 9875080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombolytic therapy: then and now.
    Cole PL
    Heart Lung; 1991 Sep; 20(5 Pt 2):542-51. PubMed ID: 1910023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of thrombolytic agents on infarct size and left ventricle systolic function in myocardial infarction].
    Bassand JP; Cassagnes J; Machecourt J; Anguenot T; Lusson JR; Borel E; Schiele F; Wolf JF; Vachet D
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():31-6. PubMed ID: 2108644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective effect of intravenous magnesium in acute myocardial infarction following thrombolytic therapy.
    Raghu C; Peddeswara Rao P; Seshagiri Rao D
    Int J Cardiol; 1999 Dec; 71(3):209-15. PubMed ID: 10636525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The cost-effectiveness of thrombolytic therapy following acute myocardial infarction.
    Fenn P; Gray AM; McGuire A
    Br J Clin Pract; 1991; 45(3):181-4. PubMed ID: 1805915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term survival benefits of thrombolysis: the Royal College of General Practitioners' myocardial infarction study.
    Gilmour KM; Iversen L; Hannaford PC
    Fam Pract; 2015 Apr; 32(2):192-7. PubMed ID: 25715964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GREAT: 10 year survival of patients with suspected acute myocardial infarction in a randomised comparison of prehospital and hospital thrombolysis.
    Rawles J;
    Heart; 2003 May; 89(5):563-4. PubMed ID: 12695474
    [No Abstract]   [Full Text] [Related]  

  • 48. Prophylactic lidocaine use in acute myocardial infarction revisited in the thrombolytic era.
    Tan HL; Lie KI
    Am Heart J; 1999 May; 137(5):770-3. PubMed ID: 10220620
    [No Abstract]   [Full Text] [Related]  

  • 49. Serum myoglobin and creatine kinase enzymes in acute myocardial infarction treated with Anistreplase.
    McCullough DA; Harrison PG; Forshall JM; Irving JB; Hillman RJ
    J Clin Pathol; 1992 May; 45(5):405-7. PubMed ID: 1597518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Earliest electrocardiographic evidence of myocardial infarction: implications for thrombolytic treatment. The GREAT Group.
    Adams J; Trent R; Rawles J
    BMJ; 1993 Aug; 307(6901):409-13. PubMed ID: 8267742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safe use of thrombolysis in the elderly.
    Wittry MD; Thornton TA; Chaitman BR
    Geriatrics; 1989 Nov; 44(11):28-30, 33-6. PubMed ID: 2509296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The safety of the treatment of an acute myocardial infarct by immediate intravenous fibrinolysis in the regional hospital environment].
    Bermejo García J; Casero Lambás A; Durán Hernández JM; Alonso Martín J; Ramos López B; Muñoz San José JC; Guillem Ares E; Bartolomé Aragón A; Gamazo Chillón F; San José Díez J
    Rev Esp Cardiol; 1994 Oct; 47(10):666-71. PubMed ID: 7991919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of APSAC in the treatment of acute myocardial infarction.
    Machraoui A; Jäger D; Barmeyer J; Armbrecht J
    Eur Heart J; 1992 Jun; 13(6):818-23. PubMed ID: 1623874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial.
    Al-Khatib SM; Stebbins AL; Califf RM; Lee KL; Granger CB; White HD; Armstrong PW; Topol EJ; Ohman EM;
    Am Heart J; 2003 Mar; 145(3):515-21. PubMed ID: 12660676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A review of the long term effects of thrombolytic agents.
    van Domburg RT; Boersma E; Simoons ML
    Drugs; 2000 Aug; 60(2):293-305. PubMed ID: 10983734
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravenous thrombolytic therapy in myocardial infarction: an analytical review.
    Shammas NW; Zeitler R; Fitzpatrick P
    Clin Cardiol; 1993 Apr; 16(4):283-92. PubMed ID: 8458108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombolytic therapy for acute myocardial infarction. Are inclusion criteria too stringent?
    Handlin LR; Vacek JL
    Postgrad Med; 1994 Mar; 95(4):77-82. PubMed ID: 8121861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pre-hospital thrombolysis, is it useful?
    Castaigne AD; Hervé C; Duval-Moulin AM; Gaillard M; Dubois-Randé JL; Lellouche D
    Eur Heart J; 1990 Aug; 11 Suppl F():43-7. PubMed ID: 2226540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Thrombolytic therapy in acute myocardial infarct].
    Verstraete M
    Recenti Prog Med; 1990 Apr; 81(4):287-98. PubMed ID: 2198644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.